CN Patent

CN116903706B — 一种棘白菌素类药物及其制备方法和用途

Assigned to Shenzhen Xianggen Biological Co ltd · Expires 2024-05-17 · 2y expired

What this patent protects

本发明公开了一种新化合物，如式I所示化合物或其药学上可接受的盐、或其异构体。该化合物具有良好的抑制真菌的作用，可有效用于预防或治疗真菌感染，是一种更为高效的新一代棘白菌素类药物。

USPTO Abstract

本发明公开了一种新化合物，如式I所示化合物或其药学上可接受的盐、或其异构体。该化合物具有良好的抑制真菌的作用，可有效用于预防或治疗真菌感染，是一种更为高效的新一代棘白菌素类药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN116903706B
Jurisdiction
CN
Classification
—
Expires
2024-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Xianggen Biological Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.